Problem Solution: Gene One
Gene One’s success as a private research-based company allowed it to grow from a $2 million start-up to a $400 million company with excellent growth potential. Over its eight-year history, a group of talented and creative people has joined the firm. Despite some setbacks in the biotechnical field due to prior scandal in the industry, Wall Street is showing an increased interest in this industry. GO’s Board of Directors and its CEO have established three main goals (a) make the company competitive by enabling it to keep pace with demand, (b) realize annual growth of 40%, and (c) go public within three years. GO will have to overcome a number of obstacles to accomplish these goals, not the least of which is internal resistance to these initiatives. Gene One’s CEO, Don Ruiz, although a creative young entrepreneur, is inexperienced in many of the areas which need addressing. However, he is intelligent enough to realize the areas in which he needs training and assistance. GO’s mission to become a public company within three years should be attainable with a feasible strategy and determination.
Situation Analysis
Issue and Opportunity Identification
Gene One’s CEO and Board of Directors believe that the company must go public in order to realize an annual growth rate of 40% per year and to keep up with the demands of the industry. This vision brings with it numerous issues to be resolved and opportunities to be realized, including (a) obtaining investors for its IPO, (b) allaying the skepticism of key personnel fearful of taking this research-based company public, (c) persuading employees to remain positive during the transition, (d) maintaining a high level of corporate social responsibility, (e) resolving various con ...